Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 15,878 | 12,454 | 7,369 | 1,907 | 1,084 |
| Cost of Goods | 1,455 | 1,141 | 556 | 129 | 69 |
| Gross Profit | 14,423 | 11,313 | 6,813 | 1,778 | 1,014 |
| Operating Expenses | 68,097 | 72,788 | 63,305 | 66,779 | 50,169 |
| Operating Income | -53,219 | -61,334 | -55,937 | -64,872 | -49,086 |
| Other Income | 484 | 645 | 753 | 1,160 | 1,678 |
| Pre-tax Income | -52,735 | -60,689 | -55,184 | -63,712 | -47,407 |
| Income Tax | 5 | 11 | N/A | N/A | 3 |
| Net Income Continuous | -52,740 | -60,700 | -55,184 | -63,712 | -47,411 |
| Net Income | $-52,740 | $-60,700 | $-55,184 | $-63,712 | $-47,411 |
| EPS Basic Total Ops | -0.65 | -0.75 | -0.79 | -0.96 | -0.73 |
| EPS Basic Continuous Ops | -0.65 | -0.75 | -0.79 | -0.96 | -0.73 |
| EPS Diluted Total Ops | -0.65 | -0.75 | -0.79 | -0.96 | -0.73 |
| EPS Diluted Continuous Ops | -0.65 | -0.75 | -0.79 | -0.96 | -0.73 |
| EBITDA(a) | $-54,178 | $-61,679 | $-55,658 | $-64,777 | $-49,235 |